Product details
Catalog number BNUB2753-500
Price for BNUB2753-500
Size / count 1x 500 µL
RAD51 is one of the key factors of DNA repair by homologous recombination and has been shown to have anti-apoptotic activity in tumor cells. RAD51 protein interacts with a variety of tumor suppressor proteins including p53, BRCA1 and BRCA2. Elevated expression of RAD51 enhances radio-resistance of human tumor cells. Overexpression of RAD51 protein in tumor cells renders them resistant against cytotoxic drugs like Cisplatin. RAD51 interacts with BRCA1 and BRCA2 to influence subcellular localization and cellular response to DNA damage. BRCA2 inactivation may be a key event leading to genomic instability and tumorigenesis from deregulation of RAD51. High-level expression of RAD51 has been observed in a variety of human malignancies. RAD51 overexpression correlates with histological grading of the tumor in invasive ductal mammary carcinoma. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2753), 0.2mg/mL is BNUB2753-500.
RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2753), 0.2mg/mL is available in the following size(s): 1x 500 µL.
RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2753), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2753), 0.2mg/mL is manufactured by Biotium.
Estimated delivery time for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2753), 0.2mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2753), 0.2mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.
RAD51 is one of the key factors of DNA repair by homologous recombination and has been shown to have anti-apoptotic activity in tumor cells. RAD51 protein interacts with a variety of tumor suppressor proteins including p53, BRCA1 and BRCA2. Elevated expression of RAD51 enhances radio-resistance of h
Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.
The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.
Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.